SUMMARY The patient presented with progressive joint deformity, a hoarse voice, subsequent cachexia, and myoclonic seizures. She was first seen aged 22 months and died aged 6 years. A diagnosis of Farber's disease was made by demonstrating a deficiency of acid ceramidase both in leucocytes and fibroblasts.
The patient, a female Caucasian child, was born at term after an uneventful pregnancy and weighed 3*0 kg (25th centile). She was the second child born to unrelated parents. There was no relevant family history.
Her growth and development had been unremarkable until 8 months of age. She then became irritable, had difficulty rolling over, and was reluctant to crawl, stand, or walk.
Examination when first seen (aged 22 months) showed her height and weight to be between the 25th and 50th centile. She had a husky voice, which persisted. At laryngoscopy (Mr Devine) the vocal cords moved normally and no local pathology was seen, the hoarse voice being attributed to laryngomalacia. There were obvious joint abnormalities. There Full examination of her eyes, including the anterior chambers and fundi, was normal (Mr Dodd).
A diagnosis of juvenile arthritis was made and she was treated with ibuprofen penicillamine, and splinting of the knees.
Over the following three years despite the use of local steroids and systemic prednisolone to a maximum of 12-5 mg/day her joint problems progressed with only brief periods of improved function. At the best she could stand and take a few steps in a frame. Muscle development was always poor and terminally extreme muscle wasting was seen. She developed nodules of the tendon sheaths and joint capsules in the hands. At the age of 4 years she developed brief myoclonic seizures. These became more persistent, resulting in minor status epilepticus. Various anticonvulsants had only short term effects in controlling the seizures. She had marked growth failure, her weight not having increased from 15 months until her death at 6 years of age. She became totally deaf in the right ear with a mixed hearing loss on the left. By the age of 6 years she had limited movement of her shoulders, marked flexion deformity of elbows, hands, hips, knees, and feet with marked muscle wasting. Her reflexes, however, were normal.
Her condition continued to deteriorate with increasing feeding and respiratory difficulties and intermittent fever. She died aged 6 years and 2 559 560 Jameson, Holt, Keen undeveloped (Fig. lb) . The acetabular roofs were hypoplastic and there was an increased angle between the shafts and heads of the femora (coxa vara). The iliac bones were very vertical. Table 1) .
The typical history together with the low levels of cellular acid ceramidase are diagnostic of Farber's disease.
Discussion
Farber first described this disorder in 1957.' It is a rare progressive disorder associated with deficiency of lysosomal acid ceramidase and has been described in some detail by Moser and Chen,2 who found descriptions of only 27 children in the literature. Inheritance is of autosomal recessive character.
The usual onset is before the age of 1 year. Characteristic features include painful, deformed joints, in particular, proximal and distal interphalangeal and metacarpal joints, wrist, elbow, knee, ankle, and metatarsals. Suggestive features include a hoarse voice, subcutaneous nodules, feeding and respiratory difficulties, poor weight gain, and intermittent fever. All of these occurred in our patient. Glossal enlargement and hepatosplenomegaly were not seen, however, unlike the cases described by Toppet et al.3
The neurological degeneration seen in this child is less frequently found. Moser and Chen found that 10 out of 27 reported children had severe progressive impairment of psychomotor development. Only two had salaam type seizures. Twelve had evidence of peripheral nerve involvement. This child therefore is the only case reported with progressive myoclonic seizures and minor status epilepticus.
There is no specific therapy for Farber's disease. Diagnosis is important. It is an autosomal recessive condition. Heterozygotes have intermediate levels of lysosomal acid ceramidase. Antenatal diagnosis is possible using cultured skin cells from the amniotic fluid to assay the acid ceramidase, making possible the selective abortion of affected fetuses.
